Remove Acquisition Remove Blogging Remove Capital Remove San Diego
article thumbnail

Viracta, Neurelis & More: The Latest in San Diego Biotech

Xconomy

Even as all eyes were on the American Society of Hematology (ASH) conference in downtown San Diego this week, other biotech companies were staying busy. Let’s get caught up with the latest life sciences news in San Diego. The San Diego biotech is developing therapies for cancers related to the Epstein-Barr virus.

article thumbnail

Colorado’s Webroot Buys CyberFlow Analytics, Expands in San Diego

Xconomy

Not long after ViaSat (NASDAQ: VSAT ) acquired San Diego-based LonoCloud in 2013 , former LonoCloud executives Tom Caldwell and Hossein Eslambolchi met for coffee at the Specialty’s Café and Bakery in University City. Webroot also plans to expand in San Diego, and Caldwell said he plans to stay on.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

San Diego Innovation Economy Extended Gains in 2015: Connect Report

Xconomy

The Connect Innovation Report found that 405 software, technology, and life sciences startups were created last year in San Diego County. Innovation Companies in San Diego (Courtesy Connect Innovation Report).

article thumbnail

ResMed Boosts Connected Health Play With $225M Propeller Health Deal

Xconomy

The acquisition, which is expected to close by the end of March 2019, continues San Diego-based ResMed’s (NYSE: RMD ) “connected healthcare” push that began about five years ago, as Xconomy chronicled last year. [ Updated 12/3/18, 3:30 pm, with CEO comments.

article thumbnail

Reneo Pharma Launches with $50M to Target Energy-Depleting Diseases

Xconomy

Yet another new biotech company has been founded in San Diego by serial entrepreneur Mike Grey and other alumni of rare disease startup Lumena Pharmaceuticals. Grey, who was president and CEO of Lumuna from 2011 through its 2014 acquisition by Irish drugmaker Shire (now part of Japan’s Takeda Pharmaceutical.

article thumbnail

Dell Technologies Goes Public About $100M Venture Capital Arm

Xconomy

Austin —Dell Technologies is publicly unveiling a venture capital investment arm that has been quietly investing in startups since the operation was run by EMC, the data storage giant that Dell agreed to acquire for $67 billion in 2015. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

article thumbnail

NeoGenomics Buys Ex-Novartis Cancer Lab Genoptix for $125M, Stock

Xconomy

The buyout comes almost two years after Carlsbad, CA-based Genoptix was bought from Novartis (NYSE: NVS ) by a pair of private investment firms, Ampersand Capital Partners and 1315 Capital, and a management group for an undisclosed sum in January 2017. Joseph Limber became the CEO of the company.